| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.02 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |